199 related articles for article (PubMed ID: 27708130)
1. Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.
Mattis PJ; Niethammer M; Sako W; Tang CC; Nazem A; Gordon ML; Brandt V; Dhawan V; Eidelberg D
Neurology; 2016 Nov; 87(18):1925-1933. PubMed ID: 27708130
[TBL] [Abstract][Full Text] [Related]
2. Metabolic brain networks associated with cognitive function in Parkinson's disease.
Huang C; Mattis P; Tang C; Perrine K; Carbon M; Eidelberg D
Neuroimage; 2007 Jan; 34(2):714-23. PubMed ID: 17113310
[TBL] [Abstract][Full Text] [Related]
3. Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer's disease topography.
Perovnik M; Tomše P; Jamšek J; Tang C; Eidelberg D; Trošt M
Neuroimage Clin; 2022; 35():103080. PubMed ID: 35709556
[TBL] [Abstract][Full Text] [Related]
4. Abnormal metabolic pattern associated with cognitive impairment in Parkinson's disease: a validation study.
Meles SK; Tang CC; Teune LK; Dierckx RA; Dhawan V; Mattis PJ; Leenders KL; Eidelberg D
J Cereb Blood Flow Metab; 2015 Sep; 35(9):1478-84. PubMed ID: 26058693
[TBL] [Abstract][Full Text] [Related]
5. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
Passamonti L; Vázquez Rodríguez P; Hong YT; Allinson KS; Williamson D; Borchert RJ; Sami S; Cope TE; Bevan-Jones WR; Jones PS; Arnold R; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
Brain; 2017 Mar; 140(3):781-791. PubMed ID: 28122879
[TBL] [Abstract][Full Text] [Related]
6. Changes in network activity with the progression of Parkinson's disease.
Huang C; Tang C; Feigin A; Lesser M; Ma Y; Pourfar M; Dhawan V; Eidelberg D
Brain; 2007 Jul; 130(Pt 7):1834-46. PubMed ID: 17470495
[TBL] [Abstract][Full Text] [Related]
7. Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment.
Hosokai Y; Nishio Y; Hirayama K; Takeda A; Ishioka T; Sawada Y; Suzuki K; Itoyama Y; Takahashi S; Fukuda H; Mori E
Mov Disord; 2009 Apr; 24(6):854-62. PubMed ID: 19199357
[TBL] [Abstract][Full Text] [Related]
8. Cortical Metabolic and Cognitive Correlates of Disorientation in Alzheimer's Disease.
Weissberger GH; Melrose RJ; Fanale CM; Veliz JV; Sultzer DL
J Alzheimers Dis; 2017; 60(2):707-719. PubMed ID: 28869474
[TBL] [Abstract][Full Text] [Related]
9. Stereotyped Relationship Between Motor and Cognitive Metabolic Networks in Parkinson's Disease.
Rus T; Schindlbeck KA; Tang CC; Vo A; Dhawan V; Trošt M; Eidelberg D
Mov Disord; 2022 Nov; 37(11):2247-2256. PubMed ID: 36054380
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes in metabolic network activity in early Alzheimer's disease.
Perovnik M; Tang CC; Namías M; Eidelberg D;
Alzheimers Dement; 2023 Sep; 19(9):4061-4072. PubMed ID: 37204815
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal change of biomarkers in cognitive decline.
Lo RY; Hubbard AE; Shaw LM; Trojanowski JQ; Petersen RC; Aisen PS; Weiner MW; Jagust WJ;
Arch Neurol; 2011 Oct; 68(10):1257-66. PubMed ID: 21670386
[TBL] [Abstract][Full Text] [Related]
12. PET network abnormalities and cognitive decline in patients with mild cognitive impairment.
Devanand DP; Habeck CG; Tabert MH; Scarmeas N; Pelton GH; Moeller JR; Mensh BD; Tarabula T; Van Heertum RL; Stern Y
Neuropsychopharmacology; 2006 Jun; 31(6):1327-34. PubMed ID: 16292330
[TBL] [Abstract][Full Text] [Related]
13. Metabolic correlates of executive dysfunction. Different patterns in mild and very mild Alzheimer's disease.
Bracco L; Bessi V; Piccini C; Mosconi L; Pupi A; Sorbi S
J Neurol; 2007 Aug; 254(8):1052-65. PubMed ID: 17385079
[TBL] [Abstract][Full Text] [Related]
14. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.
Wirth M; Villeneuve S; Haase CM; Madison CM; Oh H; Landau SM; Rabinovici GD; Jagust WJ
JAMA Neurol; 2013 Dec; 70(12):1512-9. PubMed ID: 24166579
[TBL] [Abstract][Full Text] [Related]
15. Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.
Habeck C; Risacher S; Lee GJ; Glymour MM; Mormino E; Mukherjee S; Kim S; Nho K; DeCarli C; Saykin AJ; Crane PK;
Brain Imaging Behav; 2012 Dec; 6(4):568-83. PubMed ID: 23179062
[TBL] [Abstract][Full Text] [Related]
16. Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study.
Del Sole A; Clerici F; Chiti A; Lecchi M; Mariani C; Maggiore L; Mosconi L; Lucignani G
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1357-66. PubMed ID: 18418593
[TBL] [Abstract][Full Text] [Related]
17. Plasma tau in Alzheimer disease.
Mattsson N; Zetterberg H; Janelidze S; Insel PS; Andreasson U; Stomrud E; Palmqvist S; Baker D; Tan Hehir CA; Jeromin A; Hanlon D; Song L; Shaw LM; Trojanowski JQ; Weiner MW; Hansson O; Blennow K;
Neurology; 2016 Oct; 87(17):1827-1835. PubMed ID: 27694257
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic correlates of metabolic network activity in Parkinson's disease.
Holtbernd F; Ma Y; Peng S; Schwartz F; Timmermann L; Kracht L; Fink GR; Tang CC; Eidelberg D; Eggers C
Hum Brain Mapp; 2015 Sep; 36(9):3575-85. PubMed ID: 26037537
[TBL] [Abstract][Full Text] [Related]
19. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
20. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
